JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MEGIBOW, R. S.
Right arrow Articles by KATZ, L. N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by MEGIBOW, R. S.
Right arrow Articles by KATZ, L. N.
Journal of Pharmacology And Experimental Therapeutics, Vol. 70, Issue 4, 388-399, 1940
Copyright © 1940 by American Society for Pharmacology and Experimental Therapeutics


FURTHER STUDIES ON A-V CONDUCTIVITY

R. S. MEGIBOW 1 and L. N. KATZ 1

1 From the Cardiovascular Department, Michael Reese Hospital, Chicago, Ill.

1. The effect of various procedures on A-V conductivity was studied by noting their influence on the ventricular rate in faradically maintained auricular fibrillation. Innervated and denervated heart preparations were employed to differentiate between direct and indirect influences.

2. Asphyxia at first produced enhancement and later, as it became more advanced, depression of A-V conductivity. These effects are shown to be due primarily to a direct action on the heart. Nerve influences tend to moderate them. Both anoxemia and hypercapnia, which are the two components of asphyxia, share in both these effects. Evidence is given to show that the enhancing action of asphyxia on A-V conduction is not propagated by means of epinephrine.

3. Experiences with hypocapnia, hypercapnia, and the results of intravenous injection of NH4Cl and NaHCO3 suggest that slight deviations of the blood pH to either side of the control level in these experiments enhance A-V conduction, and that more extreme deviations of acidity and alkalinity both lead to depression of A-V conductivity.

4. Paredrine hydrobromide, through a direct action on the heart, enhances A-V conduction, its effect in the innervated heart being modified by reflex activity.

5. Barium chloride enhances A-V conduction through a direct effect upon the heart. Minor changes which occur occasionally in the innervated heart depend upon the opposite reflex vagal action of barium.

6. Atropine sulfate enhances A-V conduction in the innervated heart through its vagus action but depresses A-V conduction in the denervated heart through a direct action on the conducting tissues.

7. Quinidine sulfate, in the denervated heart, depresses A-V conduction through a direct action. In the innervated heart, this is occasionally masked by a reflex action which may actually lead to a resulting slight enhancement of A-V conduction.

8. The indirect actions of paredrine hydrobromide, barium chloride and quinidine sulfate appear to be the result of a reflex accompanying the blood pressure changes they produce. The indirect effects of these drugs may require abolition in some way when the therapeutic direct effects of the drug is sought.

Submitted on July 29, 1940







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1940 by the American Society for Pharmacology and Experimental Therapeutics.